1 |
Yang D, Weng H, Wang R, Li Y, Zhang H, Shao S, Huang H, Song Y, Chen X, Hou D, Wu Y, Lu X, Yang W, Chen Z, Hu X, Xuan J, Bai C, Wang Y. Evaluation of COVID-19 vaccines in primary prevention against infections and reduction in severity of illness following the outbreak of SARS-CoV-2 omicron variant in Shanghai. Front Med (Lausanne) 2023;10:1079165. [PMID: 36844224 DOI: 10.3389/fmed.2023.1079165] [Reference Citation Analysis]
|
2 |
Lau CS, Thundyil J, Oh MLH, Phua SK, Liang YL, Li Y, Huo J, Huang Y, Zhang B, Xu S, Aw TC. Neutralizing and Total/IgG Spike Antibody Responses Following Homologous CoronaVac vs. BNT162b2 Vaccination Up to 90 Days Post-Booster. Antibodies (Basel) 2022;11. [PMID: 36412836 DOI: 10.3390/antib11040070] [Reference Citation Analysis]
|
3 |
Ranzani OT, Hitchings MDT, de Melo RL, de França GVA, Fernandes CFR, Lind ML, Torres MSS, Tsuha DH, David LCS, Said RFC, Almiron M, de Oliveira RD, Cummings DAT, Dean NE, Andrews JR, Ko AI, Croda J. Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil. Nat Commun 2022;13:5536. [PMID: 36202800 DOI: 10.1038/s41467-022-33169-0] [Reference Citation Analysis]
|
4 |
Ranzani OT, Hitchings MD, Leite de Melo R, de França GVA, Fernandes CDFR, Lind ML, Scaramuzzini Torres MS, Tsuha DH, David LCS, Said RFC, Almiron M, de Oliveira RD, Cummings DA, Dean NE, Andrews JR, Ko AI, Croda J. Effectiveness of an Inactivated Covid-19 Vaccine with Homologous and Heterologous Boosters against Omicron in Brazil.. [DOI: 10.1101/2022.03.30.22273193] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
|